Will Rossellini

From Wikipedia, the free encyclopedia

Will Rosellini (born July 11, 1979 in San Antonio, Texas) is a former minor league baseball player in the Arizona Diamondbacks system. He is currently President and CEO of MicroTransponder, Inc., a company commercializing advanced medical devices for the treatment of neurological disease.

[edit] Baseball career

Rosellini was a member of the 1994 Silver Medal Junior Olympic Team. He graduated from Jesuit High School in 1997 and was a member of the 1997 Bronze Medal Team USA team.[1] He attended Vanderbilt University on full scholarship as a right-handed pitcher [2]. He transferred to Oklahoma State University and was a member of the 1999 College World Series team [3][4]. Rosellini transferred to the University of Dallas and was drafted in the 16th round by the Arizona Diamondbacks. He played in 2000 at the rookie level in the Arizona and Pioneer Leagues [5][6]. In addition, Rosellini was a popular writer for Baseball America [7].

[edit] Education

  • Master's of Business Administration University of Texas, Dallas -- 2003
  • Master's of Accounting University of Texas, Dallas -- 2003
  • Juris Doctor Hofstra Law School -- 2006
  • Master's of Computational Biology Rutgers-NJIT -- 2007
  • Master's of Neuroscience University of Texas, Dallas -- 2007
  • Master's Nanoscale Physics Rice University -- 2009
  • PhD Neuroscience University of Texas, Dallas -- 2010

After retiring from professional baseball, Rossellini enrolled in the University of Texas management program. He took graduate courses from 2001 to 2003 and received a Master's of Business Administration and Master's of Accounting [8] [9].

Rossellini then was simultaneously enrolled at Hofstra University School of Law and Rutgers-New Jersey Institute of Technology's Master's of Computational Biology programs. During this time, Rossellini received numerous honors, including the Foley and Lardner Intellectual Property Writing Prize [10]. His work was recognized by the Terasem Foundation and outlined in a Mock Trial in 2006 [11]. Rossellini is currently enrolled in the Ph.D. program of Applied Cognition and Neuroscience at UTDallas and the Rice Nanoscale Physics Masters program.

[edit] Professional

He currently serves a President and CEO of MicroTransponder, Inc. The company is a University of Texas spin-out commercializing novel neuroprosthetics.